Annual CFI
-$88.49 M
-$166.93 M-212.80%
December 31, 2022
Summary
- As of February 9, 2025, TCRR annual cash flow from investing activities is -$88.49 million, with the most recent change of -$166.93 million (-212.80%) on December 31, 2022.
- During the last 3 years, TCRR annual CFI has fallen by -$68.07 million (-333.44%).
Performance
TCRR Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly CFI
$21.69 M
+$18.03 M+493.16%
March 31, 2023
Summary
- As of February 9, 2025, TCRR quarterly cash flow from investing activities is $21.69 million, with the most recent change of +$18.03 million (+493.16%) on March 31, 2023.
- Over the past year, TCRR quarterly CFI has increased by +$139.06 million (+118.48%).
Performance
TCRR Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM CFI
$50.57 M
+$139.06 M+157.15%
March 31, 2023
Summary
- As of February 9, 2025, TCRR TTM cash flow from investing activities is $50.57 million, with the most recent change of +$139.06 million (+157.15%) on March 31, 2023.
- Over the past year, TCRR TTM CFI has increased by +$106.56 million (+190.32%).
Performance
TCRR TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Cash From Investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
TCRR Cash From Investing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -212.8% | +118.5% | +190.3% |
| 3 y3 years | -333.4% | +221.5% | +59.3% |
| 5 y5 years | -1253.4% | +257.9% | +347.7% |
TCRR Cash From Investing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -212.8% | at low | -39.0% | -641.2% | -35.5% | -320.9% |
| 5 y | 5-year | -212.8% | at low | -52.2% | -641.2% | -50.0% | -320.9% |
| alltime | all time | -212.8% | at low | -52.2% | -641.2% | -50.0% | -362.2% |
TCR2 Therapeutics Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2023 | - | $21.69 M(+493.2%) | $50.57 M(-157.2%) |
| Dec 2022 | -$88.49 M(-212.8%) | $3.66 M(-89.7%) | -$88.49 M(-18.8%) |
| Sep 2022 | - | $35.56 M(-444.1%) | -$108.92 M(-2.5%) |
| Jun 2022 | - | -$10.33 M(-91.2%) | -$111.73 M(+99.6%) |
| Mar 2022 | - | -$117.37 M(+599.3%) | -$55.99 M(-171.4%) |
| Dec 2021 | $78.45 M(-260.3%) | -$16.78 M(-151.2%) | $78.45 M(-22.4%) |
| Sep 2021 | - | $32.76 M(-27.9%) | $101.05 M(-3255.8%) |
| Jun 2021 | - | $45.41 M(+166.1%) | -$3.20 M(-77.2%) |
| Mar 2021 | - | $17.06 M(+193.2%) | -$14.03 M(-71.3%) |
| Dec 2020 | -$48.94 M | $5.82 M(-108.1%) | -$48.94 M(+71.3%) |
| Sep 2020 | - | -$71.50 M(-306.7%) | -$28.57 M(-146.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2020 | - | $34.58 M(-293.8%) | $61.21 M(+92.9%) |
| Mar 2020 | - | -$17.84 M(-168.1%) | $31.74 M(-255.5%) |
| Dec 2019 | -$20.41 M(-73.3%) | $26.19 M(+43.2%) | -$20.41 M(-79.4%) |
| Sep 2019 | - | $18.28 M(+258.0%) | -$98.96 M(-12.9%) |
| Jun 2019 | - | $5.11 M(-107.3%) | -$113.64 M(-14.3%) |
| Mar 2019 | - | -$70.00 M(+33.7%) | -$132.60 M(+73.7%) |
| Dec 2018 | -$76.34 M(-1095.0%) | -$52.35 M(-1555.0%) | -$76.34 M(+218.3%) |
| Sep 2018 | - | $3.60 M(-126.0%) | -$23.99 M(-13.0%) |
| Jun 2018 | - | -$13.85 M(+0.8%) | -$27.59 M(+100.8%) |
| Mar 2018 | - | -$13.74 M | -$13.74 M |
| Dec 2017 | $7.67 M(-183.2%) | - | - |
| Dec 2016 | -$9.22 M | - | - |
FAQ
- What is TCR2 Therapeutics annual cash flow from investing activities?
- What is the all time high annual CFI for TCR2 Therapeutics?
- What is TCR2 Therapeutics annual CFI year-on-year change?
- What is TCR2 Therapeutics quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for TCR2 Therapeutics?
- What is TCR2 Therapeutics quarterly CFI year-on-year change?
- What is TCR2 Therapeutics TTM cash flow from investing activities?
- What is the all time high TTM CFI for TCR2 Therapeutics?
- What is TCR2 Therapeutics TTM CFI year-on-year change?
What is TCR2 Therapeutics annual cash flow from investing activities?
The current annual CFI of TCRR is -$88.49 M
What is the all time high annual CFI for TCR2 Therapeutics?
TCR2 Therapeutics all-time high annual cash flow from investing activities is $78.45 M
What is TCR2 Therapeutics annual CFI year-on-year change?
Over the past year, TCRR annual cash flow from investing activities has changed by -$166.93 M (-212.80%)
What is TCR2 Therapeutics quarterly cash flow from investing activities?
The current quarterly CFI of TCRR is $21.69 M
What is the all time high quarterly CFI for TCR2 Therapeutics?
TCR2 Therapeutics all-time high quarterly cash flow from investing activities is $45.41 M
What is TCR2 Therapeutics quarterly CFI year-on-year change?
Over the past year, TCRR quarterly cash flow from investing activities has changed by +$139.06 M (+118.48%)
What is TCR2 Therapeutics TTM cash flow from investing activities?
The current TTM CFI of TCRR is $50.57 M
What is the all time high TTM CFI for TCR2 Therapeutics?
TCR2 Therapeutics all-time high TTM cash flow from investing activities is $101.05 M
What is TCR2 Therapeutics TTM CFI year-on-year change?
Over the past year, TCRR TTM cash flow from investing activities has changed by +$106.56 M (+190.32%)